NCT06706414View on ClinicalTrials.gov

NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

January 31, 2026

Conditions
Infertility, Male
Interventions
DRUG

Denosumab (Prolia)

Subcutaneous injection with 60 mg Denosumab once

DRUG

Letrozole (Aromatase Inhibitors)

Letrozole oral tablet 2.5 mg once daily

Trial Locations (1)

2730

RECRUITING

Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Herlev and Gentofte Hospital, Herlev

All Listed Sponsors
lead

Martin Blomberg Jensen

OTHER